Literature DB >> 31999984

Comment on: "High released lactate by epicardial fat from coronary artery disease patients is reduced by dapagliflozin treatment".

Erkan Cure1, Medine Cumhur Cure2.   

Abstract

Entities:  

Keywords:  Coronary artery disease; Dapagliflozin; Lactate euglycemic diabetic ketoacidosis; Sodium-glucose cotransporter-2 inhibitors

Mesh:

Substances:

Year:  2020        PMID: 31999984     DOI: 10.1016/j.atherosclerosis.2020.01.006

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  2 in total

1.  Comment on "Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?"

Authors:  Erkan Cure; Medine Cumhur Cure
Journal:  Diabetes Res Clin Pract       Date:  2020-04-30       Impact factor: 5.602

2.  Can dapagliflozin have a protective effect against COVID-19 infection? A hypothesis.

Authors:  Erkan Cure; Medine Cumhur Cure
Journal:  Diabetes Metab Syndr       Date:  2020-04-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.